Ocular Therapeutix Inc (OCUL)
Insider transactions
A complete record of Form 4 filings tracking every share acquisition and disposal by executives, directors, and senior officers. Filterable by date range and transaction type, the table exposes the direct market actions of those with the deepest knowledge of a company's operations — providing a factual, data-driven signal of internal conviction that complements traditional fundamental and technical analysis.
Transaction date | Executive | Executive Title | Security Type | Acquisition / Disposal | Shares | Share price |
|---|---|---|---|---|---|---|
| Aug 31, 2026 | NOTMAN, DONALD | Chief Operating Officer | Common Stock | Disposal | 1,099 | 10.24 |
| Aug 25, 2026 | DUGEL, PRAVIN | Director, See Remarks | Common Stock | Disposal | 50,092 | 0 |
| Aug 25, 2026 | DUGEL, PRAVIN | Director, See Remarks | Common Stock | Acquisition | 50,092 | 0 |
| Aug 24, 2026 | NAYAK, SANJAY | Chief Strategy Officer | Common Stock | Disposal | 1,897 | 10.78 |
| Aug 24, 2026 | HEIER, JEFFREY S. | Chief Scientific Officer | Common Stock | Disposal | 3,296 | 10.78 |
| Aug 24, 2026 | DUGEL, PRAVIN | Director, See Remarks | Common Stock | Disposal | 21,649 | 10.77 |
| Aug 24, 2026 | KAISER, PETER | Chief Development Officer | Common Stock | Disposal | 3,035 | 10.77 |
| Jun 16, 2026 | DUGEL, PRAVIN | Director, See Remarks | Common Stock | Acquisition | 50,092 | 0 |
| Jun 16, 2026 | DUGEL, PRAVIN | Director, See Remarks | Common Stock | Disposal | 50,092 | 0 |
| Jun 10, 2026 | WARDEN, CHARLES M | Director | Common Stock | Acquisition | 14,000 | 0 |
| Jun 10, 2026 | GRAVES, ADRIENNE L | Director | Common Stock | Acquisition | 14,000 | 0 |
| Jun 10, 2026 | ROBINS, JASON SHAND | Chief Financial Officer | Stock Option (Right to Buy) | Acquisition | 14,024 | 0 |
| Jun 10, 2026 | GRAVES, ADRIENNE L | Director | Stock Option (Right to Buy) | Acquisition | 44,000 | 0 |
| Jun 10, 2026 | LINDSTROM, RICHARD L MD | Director | Stock Option (Right to Buy) | Acquisition | 44,000 | 0 |
| Jun 10, 2026 | HONG, SEUNG SUH | Director | Stock Option (Right to Buy) | Acquisition | 44,000 | 0 |
| Jun 10, 2026 | WILLIAMS, LESLIE J. | Director | Common Stock | Acquisition | 14,000 | 0 |
| Jun 10, 2026 | HONG, SEUNG SUH | Director | Common Stock | Acquisition | 14,000 | 0 |
| Jun 10, 2026 | RAINES, MERILEE | Director | Stock Option (Right to Buy) | Acquisition | 44,000 | 0 |
| Jun 10, 2026 | RAINES, MERILEE | Director | Common Stock | Acquisition | 14,000 | 0 |
| Jun 10, 2026 | LINDSTROM, RICHARD L MD | Director | Common Stock | Acquisition | 14,000 | 0 |
| Jun 10, 2026 | WARDEN, CHARLES M | Director | Stock Option (Right to Buy) | Acquisition | 44,000 | 0 |
| Jun 10, 2026 | ROBINS, JASON SHAND | Chief Financial Officer | Common Stock | Acquisition | 15,441 | 0 |
| Jun 10, 2026 | WILLIAMS, LESLIE J. | Director | Stock Option (Right to Buy) | Acquisition | 44,000 | 0 |
| Jun 3, 2026 | WAHEED, NADIA | Chief Medical Officer | Common Stock | Disposal | 14,828 | 8.27 |
| May 28, 2026 | DUGEL, PRAVIN | Director, See Remarks | Common Stock | Disposal | 394,696 | 0 |
| May 28, 2026 | DUGEL, PRAVIN | Director, See Remarks | Common Stock | Acquisition | 394,696 | 0 |
| May 26, 2026 | HEIER, JEFFREY S. | Chief Scientific Officer | Common Stock | Disposal | 3,018 | 8.2 |
| May 26, 2026 | DUGEL, PRAVIN | Director, See Remarks | Common Stock | Disposal | 21,156 | 8.2 |
| May 26, 2026 | KAISER, PETER | Chief Development Officer | Common Stock | Disposal | 2,967 | 8.2 |
| May 26, 2026 | NAYAK, SANJAY | Chief Strategy Officer | Common Stock | Disposal | 1,858 | 8.2 |
| Apr 9, 2026 | DUGEL, PRAVIN | Director, See Remarks | Common Stock | Disposal | 394,696 | 0 |
| Apr 9, 2026 | DUGEL, PRAVIN | Director, See Remarks | Common Stock | Acquisition | 394,696 | 0 |
| Feb 23, 2026 | KAISER, PETER | Chief Development Officer | Common Stock | Disposal | 2,810 | 8.28 |
| Feb 23, 2026 | NAYAK, SANJAY | Chief Strategy Officer | Common Stock | Disposal | 1,759 | 8.28 |
| Feb 23, 2026 | DUGEL, PRAVIN | Director, See Remarks | Common Stock | Disposal | 20,056 | 8.28 |
| Feb 23, 2026 | HEIER, JEFFREY S. | Chief Scientific Officer | Common Stock | Disposal | 3,057 | 8.28 |
| Feb 20, 2026 | LINDSTROM, RICHARD L MD | Director | Common Stock | Acquisition | 60,229 | 7.66 |
| Feb 20, 2026 | WAHEED, NADIA | Chief Medical Officer | Common Stock | Disposal | 3,510 | 7.74 |
| Feb 12, 2026 | DUGEL, PRAVIN | Director, See Remarks | Common Stock | Disposal | 124,882 | 9.04 |
| Feb 12, 2026 | NOTMAN, DONALD | Chief Operating Officer | Common Stock | Disposal | 11,446 | 9.04 |
| Feb 12, 2026 | NAYAK, SANJAY | Chief Strategy Officer | Common Stock | Disposal | 10,348 | 9.04 |
| Feb 12, 2026 | WAHEED, NADIA | Chief Medical Officer | Common Stock | Disposal | 7,863 | 9.04 |
| Feb 4, 2026 | NOTMAN, DONALD | Chief Operating Officer | Common Stock | Disposal | 6,035 | 8.54 |
| Feb 2, 2026 | NOTMAN, DONALD | Chief Operating Officer | Common Stock | Disposal | 5,455 | 9.14 |
| Jan 21, 2026 | ROBINSON, DAVID WAYNE | Global CCO | Common Stock | Acquisition | 136,000 | 0 |
| Jan 21, 2026 | ROBINSON, DAVID WAYNE | Global CCO | Stock Option (Right to Buy) | Acquisition | 416,000 | 0 |
| Jan 20, 2026 | ROBINS, JASON SHAND | Interim CFO | Stock Option (Right to Buy) | Acquisition | 33,000 | 0 |
| Jan 2, 2026 | WAHEED, NADIA | Chief Medical Officer | Common Stock | Acquisition | 79,112 | 0 |
| Jan 2, 2026 | NOTMAN, DONALD | See Remarks | Stock Option (Right to Buy) | Acquisition | 240,932 | 0 |
| Jan 2, 2026 | SAROJ, NAMRATA | Chief Business Officer | Common Stock | Acquisition | 79,112 | 0 |
| Jan 2, 2026 | ANDERMAN, TODD | Chief Legal Officer | Stock Option (Right to Buy) | Acquisition | 197,650 | 0 |
| Jan 2, 2026 | WAHEED, NADIA | Chief Medical Officer | Stock Option (Right to Buy) | Acquisition | 240,932 | 0 |
| Jan 2, 2026 | MEYERS, STEVE LAWRENCE | Chief Commercial Officer | Stock Option (Right to Buy) | Acquisition | 197,650 | 0 |
| Jan 2, 2026 | NOTMAN, DONALD | See Remarks | Common Stock | Acquisition | 79,112 | 0 |
| Jan 2, 2026 | HEIER, JEFFREY S. | Chief Scientific Officer | Common Stock | Acquisition | 79,112 | 0 |
| Jan 2, 2026 | SAROJ, NAMRATA | Chief Business Officer | Stock Option (Right to Buy) | Acquisition | 240,932 | 0 |
| Jan 2, 2026 | KAISER, PETER | Chief Development Officer | Common Stock | Acquisition | 79,112 | 0 |
| Jan 2, 2026 | NAYAK, SANJAY | Chief Strategy Officer | Stock Option (Right to Buy) | Acquisition | 197,650 | 0 |
| Jan 2, 2026 | ANDERMAN, TODD | Chief Legal Officer | Common Stock | Acquisition | 64,900 | 0 |
| Jan 2, 2026 | NAYAK, SANJAY | Chief Strategy Officer | Common Stock | Acquisition | 64,900 | 0 |
| Jan 2, 2026 | HEIER, JEFFREY S. | Chief Scientific Officer | Stock Option (Right to Buy) | Acquisition | 240,932 | 0 |
| Jan 2, 2026 | KAISER, PETER | Chief Development Officer | Stock Option (Right to Buy) | Acquisition | 240,932 | 0 |
| Jan 2, 2026 | MEYERS, STEVE LAWRENCE | Chief Commercial Officer | Common Stock | Acquisition | 64,900 | 0 |
| Nov 26, 2025 | DUGEL, PRAVIN | Director, See Remarks | Common Stock | Disposal | 49,754 | 0 |
| Nov 26, 2025 | DUGEL, PRAVIN | Director, See Remarks | Common Stock | Acquisition | 49,754 | 0 |
| Nov 24, 2025 | HEIER, JEFFREY S. | Chief Scientific Officer | Common Stock | Disposal | 3,469 | 12.04 |
| Nov 24, 2025 | KAISER, PETER | Chief Development Officer | Common Stock | Disposal | 3,007 | 12.02 |
| Nov 24, 2025 | DUGEL, PRAVIN | Director, See Remarks | Common Stock | Disposal | 19,530 | 12.04 |
| Nov 24, 2025 | NAYAK, SANJAY | Chief Strategy Officer | Common Stock | Disposal | 1,878 | 12.04 |
| Nov 5, 2025 | SAROJ, NAMRATA | Chief Business Officer | Common Stock | Disposal | 25,865 | 10.74 |
| Oct 8, 2025 | ANDERMAN, TODD | Chief Legal Officer | Common Stock | Disposal | 11,132 | 12.34 |
| Oct 2, 2025 | HEIER, JEFFREY S. | Chief Scientific Officer | Common Stock | Disposal | 10,502 | 11.04 |
| Oct 2, 2025 | KAISER, PETER | Chief Development Officer | Common Stock | Disposal | 9,653 | 11.03 |